(
399
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Advances in understanding allergen immunotherapy, drug and food allergy
-
Are children just little adults in the drug allergy diagnostic work up?
-
Biological severe asthma treatment in Poland – pros and cons of drug programme
-
Drug allergy – time for a personalised approach
-
EAACI & AAAAI joint symposium: hot topics in drug hypersensitivity
-
Flash Talkson drug allergy
-
Flash talks on drug allergy I
-
Flash talks on drug allergy II
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Management of drug allergy
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Oral food challenges thresholds for clinical reactions
-
Predicting adverse reactions to biologicals
-
Recognizing immediate reactions in contact dermatitis
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Update on drug allergy
-
Update on practical approaches in delayed drug hypersensitivities
-
Which skin tests can be used for delayed cutaneous adverse drug reactions?
Show more Event Resources (16)Show Less-
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA Position Paper
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
EAACI/ENDA position paper on drug provocation testing
-
Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review – An EAACI position paper
-
Hypersensitivity reactions to biological agents: An EAACI position paper
-
Hypersensitivity reactions to chemotherapy: an EAACI position paper
-
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper
-
The urgent need for a harmonized severity scoring system for acute allergic reactions
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper
Show more Position Papers (13)Show Less-
-
Burden of hypersensitivity reactions to biologics
-
Challenges in Drug Allergy
-
Diagnosis and management of hypersensitivity reactions due to biologics
-
Diagnosis of Drug Allergy
-
Introduction to the Drug Allergy Modules
-
Management of Common Drug Allergies
-
Pitfalls of hypersensitivity reactions due to biologics
-
Introduction to the Drug Hypersensitivity Module: Update in hypersensitive reactions to biologicals
Show more Courses (6)Show Less-
-
Management of adverse reactions to anticoagulants
-
Recommendations for prevention and management of adverse reactions to biologics
-
Update in the classification of hypersensitivity reactions to non-steroidal anti-inflammatory drugs
-
Updated guidelines on the risk assessment and methodology of skin tests for the investigation of drug allergy
-
Clinical diagnosis and management of severe cutaneous adverse drug reactions (SCARs) in children: an ENDA/EAACI pediatric task force report
-
Mechanisms and biomarkers involved in Drug Hypersensitivity Reactions
Show more Task Forces (4)Show Less-
-
ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paper
-
Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol?
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
Show more Covid-19 (1)Show Less-
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA position paper
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
EAACI/ENDA position paper on drug provocation testing
Show more Consensus Documents (1)Show Less-
Website
Collapse
-
“In Class Cross-Reactivity” to all tested cephalosporins revealed in a patient with Cefazolin-induced Severe Cutaneous Adverse Drug Reaction
-
A 50-year history of IgE-mediated hypersensitivity reactions to Saccharomyces cerevisiae presenting with respiratory symptoms
-
A Comprehensive Decision Algorithm for Hypersensitivity Reactions to Iodinated Contrast Media in a Tertiary Care Setting
-
A Retrospective Analysis of Drug Provocation Tests in Children with Underlying Conditions
-
A case of progestogen hypersensitivity with reactions to endogenous progesterone and exogenous progestins
-
A case report of multiple drug hypersensitivity triggered by DRESS to beta-lactamase inhibitors
-
A multi center retrospective study of the incidence of systemic reactions, spontaneous abortions and pre-term birth in pregnant women who undergo specific immunotherapy for Hymenoptera venom because of severe allergic reactions to Hymenoptera venom
-
A rare case of IgE-mediated multiple drug hypersensitivity syndrome
-
Absence of alpha-tryptase isoforms is associated with less severe allergic reactions at food challenge to peanut
-
Advances in drug allergy diagnosis and management
-
Advancing Drug Allergy Diagnosis: The Role of In Vitro Tests and Biomarkers in Clinical Practice
-
Adverse reactions and complications of Allergic Skin Test (SPT) in North Indian population
-
Adverse reactions to biologicals in severe asthma
-
Adverse reactions to iodinated contrast media in a tertiary hospital
-
Adverse reactions to subcutaneous immunotherapy for mite in children and adolescents in a tertiary care center
-
Adverse reactions to sublingual immunotherapy with carbamylated allergoids of different sources in clinical studies
-
Aeroallergen sensitization in beekeepers and systemic reactions to bee venom
-
Allergic concerns in the probiotic era: a closer look at Actimel® reactions
-
Allergic reactions in school. Action protocols and legal framework
-
AllergoOncology: Non-allergic urticarial skin reactions associated with MOv18 IgE, a first-in-class IgE antibody recognizing Folate Receptor alpha (FR⍺)
-
Always in the same location. A pediatric fixed drug eruption case.
-
An eleven-year experience with drug desensitization at a fourth level center in Colombia
-
Analysis of all allergy and hypersensitivity reactions to anti-COVID19 vaccines according to the EUDRA Vigilance database
-
Analysis of all allergy and hypersensitivity reactions to anti-COVID19 vaccines according to the EUDRA Vigilance database
-
Analysis of systemic food reactions in patients sensitized to Bet v1 in Madrid (Spain)
-
Analytical testing of PQ Grass allergoid drug product using antibodies
-
Anaphylaxis after drug provocation test with iohexol
-
Anaphylaxis and drug allergy
-
Arcoxia – cause of erythema fixed drug
-
Are large local reactions a risk factor for subsequent systemic sting reactions?
-
Are large local reactions an indication for immunotherapy?
-
Artificial Intelligence approaches for advancing drug development and clinical applications
-
Assessing Beta-Lactam Skin Testing: Rediscovering Systemic Reactions
-
Assessing Hypersensitivity to Iodinated Contrast Media: Insights from Skin Testing and Drug Challenges
-
Assessment of Adverse Reactions in Children with IgE-Mediated Food Allergy Following Desensitization Protocols
-
Association of chemokine levels with types of reactions after alcohol consumption in patients with nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD)
-
Association of chemokine levels with types of reactions after alcohol consumption in patients with nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD)
-
Atypical clinical cases of fixed drug eruptions due to radiological contrast media
-
Beyond the intravenous route for drug desensitization to chemotherapeutic agents and monoclonal antibodies: Intramuscular, subcutaneous, and intraperitoneal protocols
-
Biomarker-driven drug development for allergic diseases
-
Biphasic Anaphylactic Reactions Following Lentils Ingestion
-
Blame the drug or the additive?
-
Can drug allergy develop in x-linked agammaglobulinemia (xla)? case report
-
Carbamazepine induced Drug reaction with eosinophilia and systemic symptoms (DRESS) with cross-reactivity to lamotrigine confirmed by a positive rechallenge
-
Case report: Acute systemic reactions to sublingual immunotherapy for tree pollen
-
Cephalosporine drug provocation in a population of children with confirmed serum sickness-like reaction to amoxicillin
-
Challenging decisions: Feasibility and safety of multiple low-risk drug challenges in a single clinic visit during peri-operative anaphylaxis investigation
-
Changes in temperature during allergic reactions to food in human volunteers
-
Changes in temperature during allergic reactions to food in human volunteers
-
Characterisation of allergic reactions in Swiss children with food allergies
-
Characterization patient’s cohort with drug reaction with eosinophilia and systemic symptoms during the years 2022 and 2023 at University of Chile Clinical Hospital
-
Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Features of Pediatric Cases Followed with the Diagnosis of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Single-Center Experience
-
Clinical Pathway on direct drug provocation testing
-
Clinical and Epidemiological insights into generalized bullous fixed drug eruption (GBFDE) in African TB HIV endemic settings: A comparison with Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)
-
Clinical history seen with different hypersensitivity reactions
-
Clinical phenotypes of nonsteroidal anti-inflammatory drug hypersensitivity
-
Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study
-
Co-existing Histamine Intolerance and Shrimp Allergy in Subjects with Adverse Reactions Following Shrimp Ingestion
-
Comparison of the Negative Predictive Values of One-Day and Five-Day Drug Provocation Tests in Late-Mild and Cutaneous Beta-Lactam Allergies in Children
-
Controversies in Drug Provocation Tests
-
Crossed-reactivity among Proton Pump Inhibitors in Immediate Severe Hipersensitivity Reactions
-
Current understanding of nonsteroidal anti-inflammatory drug hypersensitivity
-
Decoding adverse reactions to contrast media: a comprehensive study from Chile
-
Decreased frequency and severity of oral immunotherapy induced gastrointestinal eosinophilic reactions following revisions in treatment protocol
-
Definition of sensitization to risk molecules of systemic reactions in patients with food allergies and the significance of product labeling for their safety
-
Delayed drug hypersensitivity to bortezomib: an effective desensitization
-
Delayed hypersensitivity reactions to non steroidal anti-inflammatory drugs : a cases study
-
Desensitization Decoded: Personalized pediatric drug allergy management
-
Desensitization Protocol for Cemiplimab Immediate Hypersensitivity Reactions due to Cytokine Release in Lung Cancer: Report of 2 cases
-
Desensitization to ampicillin fixed drug eruption. Spotting the solution to fix the heart
-
Desensitization with von Willebrand factor (vWF) in a Patient with Type 3 von Willebrand Disease and Hypersensitivity Reactions to von Willebrand Factor Concentrates
-
Development of multiple drug hypersensitivity after DRESS syndrome induced by piperacillin/tazobactam
-
Differential diagnosis of Drug allergy
-
Direct drug provocation test with beta-lactams in children and adolescents
-
Documentation of drug allergy in the Electronic Health Record (EHR) at a Tertiary paediatric allergy service in the UK
-
Drug Allergy
-
Drug Allergy
-
Drug Allergy: Advances in Diagnosis, Management, and Prevention
-
Drug Allergy: Implementing the Latest EAACI Guidelines in Clinical Practice
-
Drug Allergy: Today and Tomorrow
-
Drug Allergy: from bench to bedside
-
Drug Induced Anaphylaxis Maybe The Only Manifestation of Systemic Mastocytosis
-
Drug Reaction With Eosinophilia and Systemic Symptoms: Deciphering the diversity of systemic immune profiles
-
Drug Reaction With Eosinophilia and Systemic Symptoms: Deciphering the diversity of systemic immune profiles
-
Drug allergy
-
Drug allergy
-
Drug allergy – Session 1: Diagnosis
-
Drug allergy 01
-
Drug allergy 02
-
Drug allergy 03
-
Drug allergy 04
-
Drug allergy 05
-
Drug allergy 06
-
Drug allergy 07
-
Drug allergy 1
-
Drug allergy 2
-
Drug allergy 3
-
Drug allergy 4
-
Drug allergy 5
-
Drug allergy 6
-
Drug allergy 7
-
Drug allergy 8
-
Drug allergy during childhood
-
Drug allergy severity and quality of life: Data from the BIOGRIAL study
-
Drug desensitization in pediatric patients – A challenging, effective and safe approach
-
Drug provocation test to acetyl salicylic acid in a children cohort
-
Drug provocation tests with beta-lactam – from suspicion to confirmation
-
Drug provocation tests: which protocol to follow?
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) caused by bortezomib and trimethoprim/sulfamethoxazole
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) concomitant to SARS cov2 infection induced by sulfasalazine with a relapse to mesalasine
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a Romanian University Hospital
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Drug – induced anaphylaxis in childhood
-
Drug-induced bullous drug eruptions: a case series
-
Dupilumab-Induced Diffuse Eosinophilic Drug Rash with Hypereosinophilia in a Patient with Idiopathic Pulmonary Fibrosis and Severe Asthma Exacerbation: A First Case Report
-
EAACI position paper about basophil activation test in immediate drug hypersensitivity
-
Early inflammatory reactions in mice after immunotherapy with an allergen microcrystalline tyrosine adsorbate
-
Efficacy and Safety of Chemotherapeutic Drug Desensitization in Children
-
Efficacy and Safety of Omalizumab in Treating Severe Allergic Reactions with Urticaria as the Initial Symptom
-
Epidemiology and clinical management of drug allergy
-
Evaluation of Awareness Regarding Drug Allergy and Rational Use Of Medicines Among Parents of Hospitalized Pediatric Patients
-
Evaluation of Direct Oral Provocation Test Results in Mild Cutaneous Reactions to Cephalosporins in Children
-
Evaluation of Immediate-Type Allergic Reactions to Amide Group Local Anesthetics In Children: A Single-Center
-
Evaluation of KIT D816V allelic burden and its correlation with the severity of anaphylactic reactions in patients with systemic mastocytosis
-
Evaluation of MRGPRX2-mediated mast cell activation in immediate hypersensitivity reactions to neuromuscular blocking agents
-
Evaluation of allergy to eight different soy products: soy dairy caused the most frequent and severe reactions
-
Evaluation of risk factors causing diagnostic delay in non-steroidal anti-inflammatory drug -exacerbated respiratory disease
-
Evaluation of the Potential for Sebetralstat to Cause Pseudo-allergic Reactions
-
Exploring Drug Hypersensitivity in Pediatric Patients with Chronic Spontaneous Urticaria: ‘’A Comprehensive Analysis Using Diagnostic Tests”
-
Factors associated with severity of reactions during oral food challenge test
-
Features of Perioperative Hypersensitivity Reactions Manifestations in Children with Bronchial Asthma
-
Ferric Carboxymaltose Hypersensitivity Reactions
-
Fixed Drug Eruption and Its Rare Variants as Food-Related and Generalized Bullous Lesions; A Tale of Three Cases
-
Fixed Drug Eruption and Its Rare Variants as Food-Related and Generalized Bullous Lesions; A Tale of Three Cases
-
Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool
-
Fixed Drug Eruption related to the use of NSAIDs
-
Fixed Drug Eruption to aminopenicillins: a case series
-
Fixed drug eruption caused by co-amoxiclav
-
Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib
-
Fixed drug eruption caused by lansoprazole
-
Fixed drug eruption caused by lansoprazole
-
Fixed drug eruption due to Levofloxacin
-
Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study
-
Flash talks on Drug Allergy 1
-
Flash talks on Drug Allergy 2
-
Flow cytometric based lymphocyte activation test measuring CD69 upregulation by an absolute count-based T-cell analysis in patients with delayed-type reactions to beta-lactam antibiotics
-
Flow cytometric based lymphocyte activation test measuring CD69 upregulation by an absolute count-based T-cell analysis in patients with delayed-type reactions to beta-lactam antibiotics
-
Food hypersensitivity reactions in adults: A longitudinal cohort study
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Food provision experience of inpatients with adverse food reactions in the acute hospital setting
-
Food-specific IgE antibody reactions and self-reported symptomatology in Spanish adults
-
Four-Year Analysis of the Incidence and Clinical Features of Perioperative Hypersensitivity Reactions in the Allergy-Anaesthesia Unit, Universitary Hospital Cruz Roja
-
Frequency and characteristics of parent-reported allergic reactions to food in Albanian school- aged children
-
Frequency and severity of allergic reactions to non-mandatory labelled food allergens – a data analysis from the Anaphylaxis Registry and the EuroPrevall outpatient clinic study
-
Frequency of Long-Term Development of Nonsteroidal Anti-Inflammatory Drug (NSAID) Hypersensitivity in Patients who Underwent Nasal Polypectomy during Childhood
-
Generalised fixed drug eruption induced by propofol: A rare case of delayed type IV hypersensitivity reaction
-
Glutathione peroxidase single nucleotide polymorphisms associated with nonsteroidal anti-inflammatory drug hypersensitivity-induced urticaria/angioedema
-
Heating, cooking, and mixing food allergens: Effects on allergic reactions and dietary advice modification
-
Histamine intolerance is uncommon among Chinese patients reporting allergic reactions to shrimp
-
How and when to perform skin tests for possible drug allergy
-
How to prevent allergic reactions during commercial flights?
-
Hymenoptera venom immunotherapy with 210 minutes Ultra-Rush protocol: patient profile and potential risk factors for systemic reactions
-
Hypersensitivity Reactions to Biologics in Patients with Th1- and Th17-Driven Immune-Mediated Diseases: A Series of Three Cases
-
Hypersensitivity Reactions to Contrast Media: Reality from a Portuguese Tertiary Hospital
-
Hypersensitivity Reactions to Iodinated Contrast Media: A Single-Center Experience
-
Hypersensitivity Reactions to Iodinated Contrast Media: Insights from a Retrospective Cohort
-
Hypersensitivity Reactions to Iodinated and Gadolinium-Based Contrast Media: Clinical and Epidemiological Insights
-
Hypersensitivity Reactions to Oxaliplatin and Carboplatin: Clinical Features and Cross Reactivity
-
Hypersensitivity reactions associated with the use of food supplements containing propolis. Analysis of observations reported to the French National Agency for Food, Environmental and Occupational Health Safety (Anses)
-
Hypersensitivity reactions during therapy with platinum compounds and taxanes – who can benefit from consulting an allergist?
-
Hypersensitivity reactions during therapy with platinum compounds and taxanes – who can benefit from consulting an allergist?
-
Hypersensitivity reactions in biologicals
-
Hypersensitivity reactions to Proton pump inhibitors: Patterns of cross- reactivity in a Tunisian series
-
Hypersensitivity reactions to platinum salts and taxanes: determination of mediator release and relation with endotypes involved and reaction severity
-
Hypersensitivity reactions to xanthine oxidase inhibitors: Facts or myths ?
-
Hypersensitivity to endogenous progesterone manifested as fixed drug eruption: a case report
-
INTERESTING FACT: Delayed systemic allergic reactions to corticosteroids: Clinical symptoms y cross-reactivity
-
Identification of phycocyanin from Galderia sulphuraria as the allergen responsible for allergic reactions in exposed workers
-
Identifying Genetic Factors Regulating Human IgE-Mediated Reactions Using Whole Genome Sequencing
-
Identifying the most at-risk age-group and longitudinal trends of drug allergy labelling among 7.3 million individuals in Hong Kong
-
Immediate Hypersensitivity Reactions to Proton Pump Inhibitors – diagnostic workup
-
Immediate hypersensitivity reactions to corticosteroids: Clinical symptoms and cross-reactivity
-
Immune mechanisms behind local skin reactions to contact allergen
-
Impact of the drug allergy challenges’ outcome on children and parents
-
Incidence of Perioperative Hypersensitivity Reactions in Spanish Hospital Cohorts – A Two-Year investigation (2022-2023)
-
Incidence of Perioperative Hypersensitivity Reactions in Spanish hospitals group. Three years of study 2022 to 2024
-
Incidence of Perioperative Hypersensitivity Reactions in the Allergy-Anaesthesia Unit of Hospital Central Cruz Roja. Tree-year study
-
Increased incidence of suspected clindamycin hypersensitivity reactions in pediatric patients due to its expanded use in clinical practice
-
Innovation Hub 5 – Application of Artificial Intelligence in drug discovery: the bigger picture
-
Innovation in drug allergy education: partnerships and potential across the Asia Pacific and beyond
-
Insights from Drug Provocation Testing in Quinolone Allergy
-
Insights from Drug Provocation Testing in Quinolone Allergy
-
Intraoperative anaphylactic reactions by metamizole
-
Iodinated Contrast Media During Acute DRESS: A Hidden Risk for Future Drug Hypersensitivity?
-
Iodinated Contrast Media During Acute DRESS: A Hidden Risk for Future Drug Hypersensitivity?
-
Is Skin Testing Necessary in Mild Immediate-Type Penicillin Reactions in Children?
-
Isolated Basophils Maintain Functionality and Specificity: A Promising Prospect for Future Drug Allergy Studies
-
JMA Poster Session 4: Drug Allergy
-
Knowledge, Attitude, and Practice of Pediatric Drug Allergy among Medical Interns: A Cross-Sectional Study
-
Late reactions to wheat, butter, and vegetable margarins favour asthma, non-allergic rhinitis and Obstructive Sleep Apnea (OSA) underpinning difficulties to increase the dose of SLIT. Eviction diet ameliorates OSA and helps increasing the SLIT dose
-
Long-term outcomes of drug reaction with eosinophilia and systemic symptoms: a ten-year prospective study from a tertiary center
-
Lymphocyte transformation test in the diagnosis of DRESS Syndrome: What criteria are most effective in determining drug causality?
-
Management decisions in 13 patients with hypersensitivity reactions to chemotherapy agents
-
Management of adverse reactions to platinum based drugs in our unit in the last year
-
Management of reactions to chemotherapeutic drugs in children
-
Management of the reactions to inodiated contrast media
-
Management of the reactions to inodiated contrast media
-
Mastocytosis and drug hypersensitivity
-
Mastocytosis or Drug hypersensitivity? (Clinincal case)
-
Millet as a Rare Allergenic Source: A Case Study of Systemic Allergic Reactions
-
Misdiagnosed Drug Hypersensitivity: A 15-Year Investigation into the Rare Occurrence of True Lidocaine Allergies
-
Modified Peanut Allergen mRNA Induces Cross-Blocking Antibodies that Protect Against Allergic Reactions in an in-vivo Allergy Model
-
Multidisciplinary approach in drug allergy
-
Multiple Fixed Drug Eruption with Arylpropionics and Nolotil: A Case Report
-
Multiple detection of IgE-mediated Food reactions using Microarray technology
-
Multiple detection of IgE-mediated allergic reactions using Microarray technology
-
Navigating Oral Food and Drug Provocation Tests: Assessing Tolerance and Safety in Clinical Settings
-
Nonsteroidal anti-inflammatory drug cross-hypersensitivity phenotypes show high carbonyl levels
-
Nonsteroidal anti-inflammatory drug cross-hypersensitivity phenotypes show high carbonyl levels
-
Novel Approaches for Drug Allergy
-
Novel analytical tool supporting drug development and biomarker discovery: The era of machine learning in Allergy and Immunology
-
Novelties in severe cutaneous adverse reactions in children
-
OAS2 – Drug and Skin Allergy
-
Omalizumab Reduces Anaphylactic Reactions and Facilitates Food Introduction in Food-Allergic Children with Severe Asthma: A Case Report
-
Oral Abstract Session 1 – Contact Dermatitis/Drug Reactions
-
Our experience with rapid desensitisation in delayed hypersensitivity reactions to biological drugs
-
PDS12: Drug Allergy
-
Paediatric case of Drug Induced Enterocolitis Syndrome (DIES) due to amoxicillin
-
Paracetamol-induced fixed drug eruption: A case Series
-
Pediatric Drug Hypersensitivity
-
Pediatric drug desensitizations: National experience
-
Pembrolizumab IgE mediated drug hypersensitivity reaction and successful desensitisation
-
Perioperative Hypersensitivity Reactions in a Spanish Hospital Group
-
Pharmacogenetics of drug allergy
-
Pharmacogenomics and Precision Medicine in Drug Allergy: From Research to Clinical Application
-
Placebo and nocebo responses in drug allergy
-
Poloxamer formulation for allergen immunotherapy reduces systemic allergic reactions in a mouse model
-
Positive HLA-B*13:01 Allele in a Patient with Clinical Diagnosis of Drug Induced Eosinophilia with Systemic Symptoms (DRESS)
-
Predictive factors of breakthrough reactions during desensitization for oncological treatments
-
Prevalence and risk factors of systemic allergic reactions to bee venom among Slovenian beekeepers: implications for public health and clinical practice
-
Prevalence, Risk and Protective Factors of Anaphylactic Reactions in Patients with Mastocytosis: A Single-Center Analysis
-
Prognostic markers for drug challenges in non-steroidal anti-inflammatory drugs
-
Prognostic markers for drug challenges in non-steroidal anti-inflammatory drugs
-
Rapid drug desensitization in children: case report
-
Rapid drug desensitization to taxanes: a descriptive study from Turkey
-
Rapid drug desensitization with chemotherapy: When should omalizumab be considered?
-
Re-introduction of drugs in drug reaction with eosinophilia and systemic symptoms
-
Reactions Due to Accidental Peanut Consumption During Epicutaneous Immunotherapy for Peanut Allergy in Toddlers
-
Reflection on the Role of Basophil Activation Test in the Diagnosis of Pediatric Drug Allergy
-
Related factors to cefazolin perioperative hypersensitivity reactions
-
Relevance of Administration Route in Immediate Hypersensitivity Reactions to Fluoroquinolones
-
Relevant Aspects in the Investigation of Hypersensitivity Reactions to Non-Beta-Lactam Antibiotics
-
Retrospective Analysis of Adverse Reactions to Iodinated Contrast Media: Experience in 165 Patients
-
Retrospective Analysis of Fixed Drug Eruptions: Unveiling Clinical Patterns and Identifying Causative Drugs
-
Retrospective evaluation of the PEN-FAST tool in Patients Undergoing Prolonged Drug Provocation
-
Retrospective evaluation of the PEN-FAST tool in Patients Undergoing Prolonged Drug Provocation
-
Retrospective observational study on longitudinal trends in the severity of adverse reactions in paediatric acute Food Protein-Induced Enterocolitis Syndrome (FPIES). (Grade-severity of Recurrence of Acute FPIES – GRAF Study)
-
Review of skin testing for delay hypersensitivity drug reactions, possible covariates involved in the results
-
Review of skin testing for delay hypersensitivity drug reactions, possible covariates involved in the results
-
Riddles of drug hypersensitivity diagnosis: a case series
-
Risk Assessment of Anaphylactic Reactions to Peanut Traces in Peanut-Allergic Individuals in Germany
-
Risk Factors in Breakthrough Reactions during Monoclonal Antibody Desensitization
-
Risk factors for reactions in desensitization to penicillin of pregnant women with syphilis: a Flow chart suggestion
-
Risk of Anaphylaxis in Patients with Large Local Reactions to Hymenoptera Stings: Retrospective and Prospective study
-
Risk stratification of drug allergy in children with immediate or delayed urticaria during antibiotic treatment
-
Role of BAT in drug desensitization
-
Safety Data for House Dust Mite and Pollen Subcutaneous Allergen Immunotherapy in Children: Systemic Reactions and Risk Factors
-
Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients
-
Safety of a Three-Step Provocation Test in Mild Hypersensitivity Reactions to Beta-Lactams
-
Safety of direct and single-dose drug provocation test in low-risk penicillin allergy labels
-
Selective Facial Angioedema Induced by Propionic Acids: A Clinical Study of NSAID Idiosyncratic Reactions (Type 3a)
-
Severe reactions to the food allergen upon skin contact
-
Shedding Light on the Controversy: Are Drug Challenges with Iodinated Contrast Media Useful?
-
Should we perform prolonged drug provocation routinely?
-
Simultaneous double drug provocation test in a low risk patient to refute unlikely allergy to paracetamol and ibuprofen
-
Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions
-
Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions
-
Successful Desensitization with CFTR Modulatory Drugs in Delayed Cutaneous Hypersensitivity Reactions
-
Successful Rapid Desensitization in a Patient with Metastatic Colorectal Cancer Presenting with Regorafenib-Mediated Fixed Drug Eruption
-
Symmetrical drug-related intertriginous and flexural exanthema related to symptomatic slow-acting drug for osteoarthritis (SYSADOA) – a case report
-
Systemic Reactions in PR-10 Related Pollen Food Allergy Syndrome: An Italian Case Series
-
Systemic allergic reactions to subcutaneous allergen immunotherapy – A single center experience
-
Systemic reactions to subcutaneous immunotherapy in children
-
The First Case Report of 12-Step 3-Bag Successful Rapid Drug Desensitization to Daratumumab in a Patient with Renal Failure Due to Secondary Systemic Amyloid and Plasma Cell Dyscrasia
-
The Frequency of Previous Large Local Reactions in a Group of 158 Patients with a History of Systemic Reaction after Insect Sting
-
The Role of Medical History and Diagnostic Testing in Identifying Post-Surgical Allergic Reactions
-
The basophil activation test is the most accurate test in predicting allergic reactions during oral food challenges to baked and fresh cow’s milk
-
The challenge of drug allergy: A revised nomenclature for allergic diseases is required
-
The clinical case scenarios for management of drug allergy: to provoke, treat through, or desensitize
-
The prevalence of sensitization to major food allergens among children with seasonal allergy symptoms, skin allergy and/or complaints of allergic reactions upon consuming certain food products
-
The use of risk assessment in drug allergy
-
The value of skin testing with TNF-inhibitors in patients with local and systemic hypersensitivity reactions
-
Therapeutic drug monitoring of 6-thioguanine nucleotides
-
Threshold of Allergic Reactions to Cashew and Pistachio in a Large Israeli Population
-
Toxic-allergic reactions that occur after the use of hair dye containing para-phenylenediamine
-
Trends of drug allergy in Asia
-
Trimethoprim-induced drug reaction with eosinophilia and systemic symptoms (DRESS) associated with reactivation of human herpesvirus-7 (HHV-7)
-
Twenty-Five Years’ Experience with Immediate-Type Local Anesthetic Reactions in Children
-
Unlocking the Potential of Cytokines for Endotyping Immediate Hypersensitivity Reactions Induced by Chemotherapeutic and Biological Agents
-
Update in the diagnosis of fixed drug eruption
-
Using an Environmental Exposure Chamber (EEC) to Conduct Allergy Trials Mitigates Trial Disruptions and Provides Consistent Drug Testing Outcomes after the Trial is Resumed
-
Utility of Basophil Activation Testing in Drug and Peanut Allergy: Concordance with Clinical Outcomes
-
Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q): A Cross-Cultural Adaptation and Reliability Study
-
Visiting the emergency room with a drug allergy label. Our experience in real life
-
What Do Drug Skin Tests Tell Us About Quinolone Allergy? Adult Allergy Reference Center Experience
-
When and how can a drug provocation test be indicated in severe cutaneous adverse reactions?
-
Which skin tests can be used for delayed cutaneous adverse drug reactions?
-
Adverse reactions to biologicals:in vivo allergy tests as a reliable tool in hypersensitivity reactions to erenumab
-
Analysis of adverse drug reactions to iodinated contrast media in a tertiary hospital: A 9-year experience
-
Descriptive bias in the clinical history of adverse drug reactions in children
-
Drug Hypersensitivity Reactions In A Pediatric Population Before And After COVID-19 Pandemic – A Retrospective Study In A Portuguese Hospital Center
-
Drug allergy – Session 2: Precision medicine in drug allergy
-
Drug provocation using two equal doses in patients with suspected drug allergy
-
Early Use Of Intravenous Methylprednisolone Attenuates Positive Challenge Reactions During Sequential Additive Drug Challenge
-
Evaluation of fixed drug eruption – skin test or drug provocation test?
-
Extensive allergological workup in the management of immediate adverse drug reactions to chemotherapy- a single centre experience
-
First-line anti-tuberculosis drug challenge reactions in DRESS in an HIV endemic setting
-
Fixed Drug Eruption induced by acetylsalicylic acid – a successful desensitization in delayed-type drug hypersensitivity
-
How to reintroduce drugs in cutaneous adverse drug reactions
-
Initial Drug Provocation Test with acetylsalicylic acid is less time consuming for the diagnosis of Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory drugs in pediatric age
-
Initial Drug Provocation Test with acetylsalicylic acid is less time consuming for the diagnosis of Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory drugs in pediatric age
-
Is premedication useful to prevent non-IgE mediated immediate drug hypersensitivity reactions
-
Management of delayed drug hypersensitivity reactions
-
Multidisciplinary approach in the management of hypersensitivity reactions to biological agents and successful rapid drug desensitization
-
Platinum drug hypersensitivity reactions – diagnosis and management with desensitization
-
Practical management of cutaneous adverse drug reactions
-
Recognizing and Managing Severe Cutaneous Adverse Drug Reactions
-
Safety of Single-Dose Drug Provocation Test in Low Risk Non-Immediate Reactions with Beta-Lactam Antibiotics in Children
-
Successful rapid drug desensitization with adrenaline infusion pump in severe allergic reactions
-
The importance of the drug provocation test as a diagnostic tool in immediate hypersensitivity reactions to chemotherapeutics
-
The importance of the drug provocation test as a diagnostic tool in immediate hypersensitivity reactions to chemotherapeutics
-
Variability in the genes involved in the cellular redox status, and their association with drug hypersensitivity reactions to nonsteroidal anti-inflammatory drugs and ß-lactam antibiotics
-
Assessment of the Impact of Drug Provocation Testing on Anxiety in Patients Experiencing Drug Hypersensitivity Reactions
-
Assessment of the Impact of Drug Provocation Testing on Anxiety in Patients Experiencing Drug Hypersensitivity Reactions
-
Delayed-Type Drug Allergy Combined with Adverse Drug Reactions
-
Adverse drug reactions to taxanes: positive skin testing correlates with breakthrough reactions during drug desensitisation
Show more Sessions (340)Show Less-